Laxmi Dental operates on three growth engines — custom labs, which make up 62% of its revenue; clear aligners, the only Indian player with USFDA approval and paediatric dental products such as SDF, Bioflx crowns — each offering strong growth potential with expected compound annual growth rates (CAGRs) of 21%-33% over FY25-27.
